Shenzhen Weiguang Biological Products Co., Ltd. (SHE:002880)

China · Delayed Price · Currency is CNY

29.36

+0.38 (1.31%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Blood Products	1.07B	985.02M	653.93M	889.29M	894.11M
Blood Products Growth	8.80%	50.63%	-26.47%	-0.54%	10.17%
Unallocated Other Industry	10.54M	28.96M	-	18.14M	10.46M
Unallocated Other Industry Growth	-63.61%	-	-	73.48%	5.93%
Property for Rent	120.97M	34.52M	-	-	-
Property for Rent Growth	250.44%	-	-	-	-
Other	-	-	14.00M	-	-
Total	1.20B	1.05B	667.93M	907.43M	904.56M
Total Growth	14.75%	56.98%	-26.39%	0.32%	10.12%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
China	1.20B	1.05B	667.93M	907.43M	904.56M
China Growth	14.75%	56.98%	-26.39%	0.32%	10.12%
Total	1.20B	1.05B	667.93M	907.43M	904.56M
Total Growth	14.75%	56.98%	-26.39%	0.32%	10.12%

Source: S&P Global Market Intelligence.